Sun Genomics provides personalized probiotic solutions based on AI and whole-genome sequencing of the microbiome.
Sun Genomics is a microbiome health company focused on curing dysbiosis through personalized probiotics. its flagship product Floré, a microbiome test and gut probiotics solution that utilizes whole-genome sequencing to evaluate different digestive system data points and ensure that customers receive a completely personalized product that is based on their unique gut profiles. The company also offers Floré Tots, which is available for kids up to age 12 and comes in an easy digestive powder to mix with their favorite drink.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Jun 29, 2020 | Series A | $9.25M | 1 | — | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
Nascita Ventures | — | Series A |